Effectiveness and safety of serplulimab plus platinum-based chemotherapy in first-line treatment of extensive-stage small cell lung cancer liver metastases: a retrospective cohort study

This real-world study demonstrates promising effectiveness and a manageable safety profile for the combination of serplulimab with platinum-based chemotherapy in treating ES-SCLC liver metastases, which suggests that this treatment regimen may provide an attractive option for the first-line management of ES-SCLC liver metastases.